This content is machine translated Immune system becomes a data logger Bacteria with uptake function capture intestinal health Researchers at ETH Zurich, Inselspital and the University of Bern are equipping intestinal bacteria with a data logger function to monitor which genes are active in the bacteria. The microorganisms…
View Post 2 min This content is machine translated Listeria monocytogenes Infectious agent offers protection against liver cancer Liver cancer is the third leading cause of cancer-related deaths worldwide. To date, treatment options for two liver cancers, hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), have been inadequate, while new…
View Post 3 min This content is machine translated Stomach inflammations How a bacterial infection changes the tissue Infection of the gastric mucosa with the Helicobacter bacterium leads to gastric inflammation and also increases the risk of stomach cancer. A research team from Charité – Universitätsmedizin Berlin and…
View Post 5 min This content is machine translated Local therapy in HCC Interdisciplinary combination therapies on the rise Small changes made in the 2022 BCLC update may be of great impact in the local therapy of stage 0 to C HCC patients. Combination therapies and other interdisciplinary measures…
View Post 4 min This content is machine translated Irritable Bowel Syndrome High “Burden of Disease” – better quality of life as a therapeutic goal In particular, IBS patients with predominant diarrhea suffer from a high burden of disease. This is shown, among other things, by a large international survey study conducted by a Swedish…
View Post 3 min This content is machine translated Colon Cancer New therapeutic perspectives raise hope for improved overall survival This year’s ASCO brought exciting study results to light. Especially in tumors of the upper and lower gastrointestinal tract, there were developments, some of which had practice-changing potential. In metastatic colon cancer,…
View Post 1 min This content is machine translated IBD matters How do you treat patients with IBD who are at risk? Prof. Dr. med. Dr. phil. Gerhard Rogler, Clinic Director of Gastroenterology and Hepatology at the University Hospital in Zurich, and PD Dr. Sophie Restellini, Director of the Crohn’s Disease and…
View Post 3 min This content is machine translated Hepatitis C therapy Hepcare – a structured approach to successful treatment Family physicians play a key role in the elimination of hepatitis. The hepatitis C therapies available today are uncomplicated and, since the beginning of this year, can be prescribed in…
View Post 1 min This content is machine translated Advanced training Launch event for interdisciplinary training on new treatment in ulcerative colitis On 01.09.2022 the interdisciplinary training on the treatment of ulcerative colitis incl. Discussion panel chaired by Prof. Dr. med. Dr. phil. Gerhard Rogler takes place. Registration for participation in the…
View Post 3 min This content is machine translated Visceral hypersensitivity Menthacarin regulates intracellular calcium ion influx in a mouse model. The phytotherapeutic agent menthacarin has been used for decades to treat functional gastrointestinal disorders. The effect is based, among other things, on inhibition of visceral hypersensitivity. Current knowledge suggests that…
View Post 4 min This content is machine translated Cardio-renal-metabolic syndrome Targeted complication management in light of risk components. Patients with diabetes mellitus and obesity are at high risk for developing cardiovascular diseases such as myocardial infarction, stroke, and heart failure. An interdisciplinary management of the cardiometabolic risk patient…
